Loading...
Ceftriaxone (Ro 13-9904) therapy of serious infection.
Ceftriaxone (Ro 13-9904), a newly developed cephalosporin with a long half-life, was evaluated for efficacy and safety in 19 patients with serious infections. Underlying illnesses were present in 16 patients. Ceftriaxone was given intravenously every 12 h. Infections treated included gram-negative b...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
1982
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC183670/ https://ncbi.nlm.nih.gov/pubmed/6289739 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|